Dissolution and drug release tests are directly relevant to the safety and efficacy of many common pharmaceutical dosage forms. To achieve reliable and reproducible results, analysts must understand the importance of correct equipment set-up, sample introduction and sampling.
In addition to use of dissolution testers, this three-day course will also cover equipment qualification, data evaluation and development and validation of dissolution procedures.
An optional half day will deal with use of dissolution testing in the assessment of bioavailability and bioequivalence.
Delegates will have the opportunity to set up and run dissolution tests using a USP I/II dissolution tester during the course and the course will include case studies and individual/group exercises.
Why do we perform dissolution testing?
Dissolution theory, sink conditions and intrinsic dissolution rate
Dissolution and drug release testing apparatus
Day 2
Requirements for different dosage form types (including data interpretation)
Day 3
Dissolution method development
Dissolution and the assessment of bioavailability/bioequivalence
In addition to use of dissolution testers, this three-day course will also cover equipment qualification, data evaluation and development and validation of dissolution procedures.
An optional half day will deal with use of dissolution testing in the assessment of bioavailability and bioequivalence.
Delegates will have the opportunity to set up and run dissolution tests using a USP I/II dissolution tester during the course and the course will include case studies and individual/group exercises.
Who should attend?
This 3.5 day hands-on course will benefit anyone requiring an intensive introduction to dissolution testing and the associated procedures working in the following areas:- Analytical Development
- Project Management
- Quality Control
- Quality Assurance
- Regulatory Affairs
- Pharmaceutical Development
鈥�Programme
Day 1Why do we perform dissolution testing?
Dissolution theory, sink conditions and intrinsic dissolution rate
Dissolution and drug release testing apparatus
- Rotating basket (USP Apparatus 1)
- Rotating paddle (USP Apparatus 2)
- Reciprocating cylinder (USP Apparatus 3)
- Flow-through cell (USP Apparatus 4)
- Paddle over disc (USP Apparatus 5)
- Rotating cylinder (USP Apparatus 6)
- Reciprocating holder (USP Apparatus 7)
- Franz cell
- Non-compendial approaches (including small-volume apparatus and peak vessels)
Day 2
Requirements for different dosage form types (including data interpretation)
- Immediate release
- Extended release
- Delayed release
- Transdermal delivery systems
- Dissolution equipment qualification
Day 3
Dissolution method development
- General requirements
- Selection of dissolution medium (including uses of biorelevant media)
- Apparatus and agitation rate
- Sampling (time points & filtration)
- Special requirements for gelatin capsules
- Assay requirements
- Setting acceptance criteria with reference to drug product specifications
- Specificity
- Linearity/range
- Accuracy/recovery
- Precision
- Robustness
- Solution stability
Dissolution and the assessment of bioavailability/bioequivalence
- Bioavailability and bioequivalence鈥攄efinitions and in vivo evaluation
- In vitro biowaivers
- In vitro-in vivo correlation
